通过SpyTag-SpyCatcher系统用于针对性乳腺癌治疗的表面功能化多基酸纳米颗粒
Jin Young Heo1, Min Kyung Sung1, Seonhye Jang1
1Department of Nanoscience and Engineering, Inje University, Gimhae 50834, Republic of Korea.
Pharmaceutics
|June 27, 2025
概括
聚氨基酸 (PHA) 纳米颗粒使用SpyTag-SpyCatcher系统进行了表面工程,以增强药物输送. 这种模块化方法使得有针对性的细胞吸收成为可能,改善了纳米医学应用.
科学领域:
- 生物材料科学 生物材料科学
- 纳米医学是一种纳米医学.
- 分子生物学分子生物学
背景情况:
- 可生物降解的聚合物,特别是聚基酸盐 (PHAs),由于其生物相容性和可持续性,对药物输送具有前景.
- 微生物组衍生PHAs为先进的治疗平台提供了一个可持续的替代方案.
- 表面功能化是提高基于纳米粒子的药物递送系统有效性的关键.
研究的目的:
- 通过SpyTag-SpyCatcher系统设计聚酸 (PHA) 纳米粒子 (NP),以改善细胞吸收.
- 研究与HER2特异性Affibody和/或TAT质功能化的PHANP的向传递能力.
- 评估连接物组成对细胞内化和治疗效果的影响.
主要方法:
- 使用mEGFP-SpyTag进行可视化的PHA NP的表面功能化.
- 与 HER2 特定的 Affibody-SpyCatcher 和/或 TAT-SpyCatcher 酸的结合,以进行向传递.
- 描述NP大小 (<200nm) 和表面电荷,并评估HER2表达细胞中的细胞吸收和细胞毒性.
主要成果:
- 在HER2-过度表达SK-BR-3细胞中,附体功能化的PHA NPs显著增加了内部化和细胞毒性.
- 通过TAT功能化的PHA NPs在各种细胞类型中表现出广泛的细胞吸收,独立于HER2表达.
- 双重功能性NP显示出基于HER2表达的多种效应,这强调了连接体选择对于有针对性的传递的重要性.
结论:
- 通过SpyTag-SpyCatcher介导的表面工程为PHA NP功能化提供了一种多功能且有效的策略.
- 这种方法可以实现模块化和强大的主动准,用于先进的纳米医学应用.
- 该研究强调了工程PHANP的潜力,以实现精确和高效的药物输送.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


